Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
GLOBETECH PUBLISHING LLC
Schiller

Electronic Nose Sniffs Out Side Effects of Radiotherapy

By Medimaging International staff writers
Posted on 05 Mar 2013
Researchers have recently completed a study that may lead to clinicians being able to more effectively predict which patients will suffer from the side effects of radiotherapy.

Gastrointestinal side effects are typical occurrences in radiotherapy patients and are at times severe, but there are no existing means of predicting which patients will suffer from them. The pilot study’s findings, published September 2012 in the journal Sensors, described how the use of an electronic nose and a newer technology, field asymmetric ion mobility spectrometry (FAIMS) might help identify those at higher risk.

University of Warwick Medical School (Coventry, UK), working in collaboration with the School of Engineering and The Royal Marsden NHS [National Health Service] Foundation Trust (London, UK), led by Dr. J. Andreyev, conducted a pilot study to look into the connection between levels of toxicity in the gut and the probability of suffering side effects.

Dr. Ramesh Arasaradnam, from Warwick Medical School and gastroenterologist at University Hospitals Coventry & Warwickshire, summarized the outcome of the study findings. “In the simplest terms, we believe that patterns in toxicity levels arise from differences in a patient's gut microflora. By using this technology we can analyze stool samples and sniff out the chemicals that are produced by these microflora to better predict the risk of side effects.”

The pilot study’s success should lead to a wider study into the possible uses of these technologies and could be truly significant in helping clinicians inform patients receiving pelvic radiotherapy, before treatment is initiated. Dr. Arasaradnam clarified what this could suggest for radiotherapy patients, “In essence, we will be able to predict those who are likely to develop severe gut related side effects by the pattern of gut fermentation that are altered as a result of radiotherapy. This will enable future directed therapy in these high risk groups.”

Dr. James Covington, from the Warwick School of Engineering, added, “This technology offers considerable opportunities for the future. This shows just one application of being able to inform treatment by ‘sniffing’ patients. We foresee a time when such technology will become as routine a diagnostic test as checking blood pressure is today.”

In 2009, the same cutting edge gas sensor technology was taken from the automotive world and used to research into faster diagnosis for some gastrointestinal illnesses and metabolic disorders.

Related Links:
University of Warwick Medical School
Royal Marsden NHS Foundation Trust


Channels

MRI

view channel
Image: MR Solutions Conversion Kit for MRI Scanner (Photo courtesy of MR Solutions).

Conversion Kit Transforms Clinical MRI System into a Preclinical Scanner

A clinical Magnetic Resonance Imaging (MRI) scanner can now be transformed into an effective preclinical system using a simple conversion kit. The transformation can be carried out in approximately... Read more

Ultrasound

view channel
Image: World’s first 29 MHz micro-ultrasound system (Photo courtesy of Exact Imaging).

Breakthrough High-Resolution Micro-Ultrasound Platform for the Prostate Revealed at AUA 2015

A novel micro-ultrasound imaging platform has been introduced at the annual meeting of the American Urological Association (AUA) 2015 (New Orleans, LA, USA). The probe operates at 29 MHz, and enables... Read more

Nuclear medicine

view channel

Human Prostate Cancer Study Evaluates New Imaging Biomarker

The results of the first human prostate cancer study intended to evaluate a 2nd generation fluorine-18 labeled small-molecule PSMA inhibitor, have been published in the April 28, 2015, issue of the Journal of Molecular Imaging and Biology. The results of the evaluation demonstrated the initial safety, bio-distribution,... Read more

General/Advanced Imaging

view channel

Global Healthcare Study of Coronary Artery Disease Reaches Significant Milestone

A major milestone has been reached in the Lipid-Rich Plaque (LRP) study, a prospective, multicenter clinical trial with the potential to reveal breakthrough correlations between Lipid-Rich Plaques and occurrence of heart attacks. The LPR study has now enrolled 1,000 patients, and aims to identify a correlation between... Read more

Imaging IT

view channel
Image: Carestream Vue Motion Viewer (Photo courtesy of Carestream Healthcare).

New Software Solution Facilitates Secure Data Aggregation from Existing Hospital IT Systems

A medical imaging systems and Information Technology (IT) solutions provider has demonstrated how its advanced healthcare IT software solutions can facilitate high-quality imaging access, and improved... Read more

Industry News

view channel

Advanced Medical Imaging Startup Company Receives Venture Funding

Zebra Medical Vision (Kibbutz Shfayim, Israel) has received an USD 8 million investment from Khosla Ventures (Menlo Park, CA, USA) to double its team, set up headquarters in the US and increase its scope of work to integrate data from additional Health Maintenance Organizations (HMO). Zebra Medical has already partnered... Read more
 

Events

31 May 2015 - 06 Jun 2015
04 Jun 2015 - 06 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.